Viewing Study NCT00315861


Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2025-12-26 @ 1:18 AM
Study NCT ID: NCT00315861
Status: COMPLETED
Last Update Posted: 2009-01-23
First Post: 2006-04-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
Sponsor: SCRI Development Innovations, LLC
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: SCRI REFMAL 72
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View
None INDUSTRY View